Tenaya Therapeutics, Inc. (TNYA) Insider Trading -- Recent Executive & Director Transactions

12 insiders reported 145 Form 4 transactions for Tenaya Therapeutics, Inc. (TNYA) over the past 18 months (most recent 2026-05-19). Recent activity: Higa Tomohiro (SVP, Finance) Sell 1,485 shares, Ali Faraz (Chief Executive Officer) Sell 3,390 shares, Tingley Whittemore (Chief Medical Officer) Sell 3,121 shares, Svennilson Peter (Insider) Sell 349,212 shares, Svennilson Peter (Insider) Sell 309,228 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-19Higa TomohiroSVP, FinanceSell1,485$1,178
2026-05-19Ali FarazChief Executive OfficerSell3,390$2,690
2026-05-19Tingley WhittemoreChief Medical OfficerSell3,121$2,477
2026-02-26Svennilson PeterInsiderSell349,212$216,511
2026-02-26Svennilson PeterInsiderSell309,228$191,721
2026-02-26Column Group Opportunity III, LPInsiderSell309,228$191,721
2026-02-26Kutzkey TimInsiderSell309,228$191,721
2026-02-26COLUMN GROUP III GP, LPInsiderSell309,228$191,721
2026-02-26Column Group Opportunity III GP, LPInsiderSell309,228$191,721
2026-02-26COLUMN GROUP III, LPInsiderSell309,228$191,721
2026-02-26COLUMN GROUP III-A, LPInsiderSell309,228$191,721
2026-02-26Column Group Opportunity III GP, LPInsiderSell349,212$216,511
2026-02-26COLUMN GROUP III GP, LPInsiderSell1.6M$923,597
2026-02-26TCG Opportunity III GP, LLCInsiderSell349,212$216,511
2026-02-26Column Group Opportunity III, LPInsiderSell349,212$216,511
2026-02-26COLUMN GROUP III GP, LPInsiderSell349,212$216,511
2026-02-26COLUMN GROUP III, LPInsiderSell349,212$216,511
2026-02-26Kutzkey TimInsiderSell349,212$216,511
2026-02-26COLUMN GROUP III-A, LPInsiderSell349,212$216,511
2026-02-26Kutzkey TimInsiderSell1.6M$923,597
2026-02-26Column Group Opportunity III GP, LPInsiderSell1.6M$923,597
2026-02-26TCG Opportunity III GP, LLCInsiderSell1.6M$923,597
2026-02-26Svennilson PeterInsiderSell1.6M$923,597
2026-02-26Column Group Opportunity III, LPInsiderSell1.6M$923,597
2026-02-26TCG Opportunity III GP, LLCInsiderSell309,228$191,721

Source: SEC Form 4 filings · as of 2026-05-19